Kelsie M Full1, Chandra L Jackson2,3, Casey M Rebholz4, Kunihiro Matsushita4, Pamela L Lutsey5. 1. Division of Epidemiology and Community Health, University of Minnesota, Minneapolis, Minnesota fullx003@umn.edu. 2. Epidemiology Branch, National Institute of Environmental Health Sciences, National Institutes of Health, Department of Health and Human Services, Chapel Hill, North Carolina. 3. Intramural Program, National Institute on Minority Health and Health Disparities, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland. 4. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland. 5. Division of Epidemiology and Community Health, University of Minnesota, Minneapolis, Minnesota.
Abstract
BACKGROUND: Obstructive sleep apnea may be associated with development of CKD through hypoxia, inflammation, and oxidative stress. Individuals with this sleep disorder are also at increased risk for established CKD risk factors, including obesity, hypertension, and type 2 diabetes. METHODS: We examined the association between obstructive sleep apnea, other sleep characteristics, and risk of incident CKD (stage 3 or higher) in 1525 participants (mean age, 62.5 years; 52.4% women) in the Atherosclerosis Risk in Communities (ARIC) study who completed in-home polysomnography assessments. We used the apnea-hypopnea index (events per hour) to define obstructive sleep apnea severity (normal, <5.0; mild, 5.0-14.9; moderate, 15.0-29.9; and severe, ≥30.0) and defined incident CKD (stage 3 or higher) as eGFR<60 ml/min per 1.73 m2 and ≥25% decline from baseline, CKD-related hospitalization or death, or ESKD. Cox proportional hazards regression was used to estimate obstructive sleep apnea severity with risk of incident CKD, adjusting for demographics, lifestyle behaviors, and cardiometabolic conditions. RESULTS: During 19 years (median) of follow-up, 461 CKD events occurred. After adjustment for demographics and lifestyle behaviors, severe obstructive sleep apnea associated with increased risk of CKD (hazard ratio [HR], 1.51; 95% confidence interval [95% CI], 1.08 to 2.10), which was attenuated after adjustment for body mass index (HR, 1.07; 95% CI, 0.75 to 1.52). No other sleep characteristics associated with incident CKD. CONCLUSIONS: We found a link between obstructive sleep apnea and an elevated risk of stage 3 CKD or higher, but this association was no longer significant after adjusting for obesity, a risk factor for both conditions. Given the high prevalence of obstructive sleep apnea and CKD among adults, further investigation is warranted.
BACKGROUND:Obstructive sleep apnea may be associated with development of CKD through hypoxia, inflammation, and oxidative stress. Individuals with this sleep disorder are also at increased risk for established CKD risk factors, including obesity, hypertension, and type 2 diabetes. METHODS: We examined the association between obstructive sleep apnea, other sleep characteristics, and risk of incident CKD (stage 3 or higher) in 1525 participants (mean age, 62.5 years; 52.4% women) in the Atherosclerosis Risk in Communities (ARIC) study who completed in-home polysomnography assessments. We used the apnea-hypopnea index (events per hour) to define obstructive sleep apnea severity (normal, <5.0; mild, 5.0-14.9; moderate, 15.0-29.9; and severe, ≥30.0) and defined incident CKD (stage 3 or higher) as eGFR<60 ml/min per 1.73 m2 and ≥25% decline from baseline, CKD-related hospitalization or death, or ESKD. Cox proportional hazards regression was used to estimate obstructive sleep apnea severity with risk of incident CKD, adjusting for demographics, lifestyle behaviors, and cardiometabolic conditions. RESULTS: During 19 years (median) of follow-up, 461 CKD events occurred. After adjustment for demographics and lifestyle behaviors, severe obstructive sleep apnea associated with increased risk of CKD (hazard ratio [HR], 1.51; 95% confidence interval [95% CI], 1.08 to 2.10), which was attenuated after adjustment for body mass index (HR, 1.07; 95% CI, 0.75 to 1.52). No other sleep characteristics associated with incident CKD. CONCLUSIONS: We found a link between obstructive sleep apnea and an elevated risk of stage 3 CKD or higher, but this association was no longer significant after adjusting for obesity, a risk factor for both conditions. Given the high prevalence of obstructive sleep apnea and CKD among adults, further investigation is warranted.
Authors: Ana C Ricardo; Kristen Knutson; Jinsong Chen; Lawrence J Appel; Lydia Bazzano; Eunice Carmona-Powell; Janet Cohan; Manjula Kurella Tamura; Susan Steigerwalt; John Daryl Thornton; Matthew Weir; Nicolas F Turek; Mahboob Rahman; Eve Van Cauter; James P Lash Journal: J Am Soc Nephrol Date: 2017-09-14 Impact factor: 10.121
Authors: A D White; A R Folsom; L E Chambless; A R Sharret; K Yang; D Conwill; M Higgins; O D Williams; H A Tyroler Journal: J Clin Epidemiol Date: 1996-02 Impact factor: 6.437
Authors: Mako Nagayoshi; Naresh M Punjabi; Elizabeth Selvin; James S Pankow; Eyal Shahar; Hiroyasu Iso; Aaron R Folsom; Pamela L Lutsey Journal: Sleep Med Date: 2016-09-29 Impact factor: 3.492
Authors: Diane S Lauderdale; Kristen L Knutson; Lijing L Yan; Paul J Rathouz; Stephen B Hulley; Steve Sidney; Kiang Liu Journal: Am J Epidemiol Date: 2006-06-01 Impact factor: 4.897
Authors: Sofia B Ahmed; Paul E Ronksley; Brenda R Hemmelgarn; Willis H Tsai; Braden J Manns; Marcello Tonelli; Scott W Klarenbach; Rick Chin; Fiona M Clement; Patrick J Hanly Journal: PLoS One Date: 2011-04-29 Impact factor: 3.240